Articles

Gen Li, Applied Clinical Trial,

January 2023:

Phesi Report: Assessing Single Patient Investigator Sites in Cancer Clinical Trials

Gen Li, Paul Chew, Jonathan Peachey, Applied Clinical Trial,

April 2022:

A Digital Twin on KRAS G12C NSCLC Patients with SCA Measured by PFS

Gen Li, Life Science Leader,

January 31, 2020:

Clinical Trial SOS

Gen Li, Clinical Leader,

April 28, 2020:

Sponsors Must Act Now to Mitigate the Impact of COVID-19 Slowdown

Gen Li, Applied Clinical Trials,

June 9, 2020:

Resurrecting Zombie Trials Will Be Another Consequence of COVID-19 Unless the Industry Acts Now

Gen Li, Paul Chew, Jonathan Peachey, International Clinical Trials,

February 2019:

The Balanced Approach to Optimising Clinical Trial Design and Execution

Gen Li, Jonathan Peachey, The Medicine Maker,

August 16, 2019:

Giving Data the Gift of Meaning

Gen Li, Karen Correa, Jonathan Peachey, Valerie Legagneur

January 17, 2018:

Enrollment Cycle Times Can and Should Be Optimized

Valerie Legagneur, Jonathan Peachey, Karen Correa, Gen Li, Applied Clinical Trials,

May 8, 2018:

Clinical Trials Don't Have to Cost Too Much or Take Too Long

Gen Li, Applied Clinical Trials,

April 1, 2015:

Forecast Enrollment Rate in Clinical Trials

Gen Li, Robert Gray, The Monitor,

2011:

Performance-Based Site Selection Reduces Costs and Shortens Enrollment Time

Li G, Harper B, Sirabella L, Parexel biopharmaceutical R&D statistical sourcebook,

2010:

Activating investigative sites in a staggered process: problems and solutions

Li G., Sirabella L., The Monitor,

2010:

Planning the Right Number of Investigative Sites for a Clinical Trial

Gen Li, Pharmaceutical Executive,

October 2, 2009:

Finding the Sweet Spot

Gen Li, Pharmaceutical Executive,

December 12, 2008:

Site Activation: The Key to More Efficient Clinical Trials

Presentations & Interviews

Dr. Paul Chew at Clinical Trials Digital Week 2021,

June 9, 2021:

Clinical Trials a la mode: Modal Values and Intelligent Trial Design

Phesi & Alfasigma Joined Demo at SCOPE 2021

March 1, 2021:

Integrated data science for clinical development & commercialization - a case study

Pharma Technology Focus,

June 26, 2020:

Salvaging clinical trials in the time of covid-19

Outsourcing Pharma,

June 8, 2020:

Phesi: COVID-19-era trials require a ‘data-driven’ approach

The Bio Report,

August 22, 2019:

Using AI to Improve Clinical Development (podcast interview with Phesi founder & president Gen Li)

The Medicine Maker,

August 2019:

Giving Data the Gift of Meaning

Outsourcing Pharma,

July 30, 2019:

Phesi’s SaaS predicts ‘what if’ and eases site selection costs, delays

PMLive,

July 8, 2019:

Streamlining clinical trials – why better data use is key

Cornell Enterprise,

February 2019:

Startup Snapshot: Big Data, Big Outcomes for New Medicines

CROWN Conference 2019,

Jan 2019:

Paul Chew Presentation – Smarter Trials = Faster Cures: 3 Things You Need to Get Right

White Papers

Joined white paper by Phesi and Accenture: Faster and cheaper clinical trials: the benefits of synthetic data.

White Paper: Clinical Development – Feasibility, Planning and Execution

Please provide your contact information below: